IDO1 and cancer: Indeed, IDO1+ cells export kynurenines, which are imported by non-IDO1-expressing cells via solute carrier transporters, and these tryptophan catabolites are converted in metabolites with anti-ferroptotic activity [179], supporting local immunosuppression and cancer cell proliferation.